Your browser doesn't support javascript.
loading
Management of Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Jiramongkolchai, Pawina; Schwartz, Marc S; Friedman, Rick A.
Afiliación
  • Jiramongkolchai P; Division of Otolaryngology-Head and Neck Surgery, University of California San Diego School of Medicine, 200 West Arbor Drive, MC 8895, San Diego, CA 92103, USA.
  • Schwartz MS; Department of Neurosurgery, University of California San Diego School of Medicine, 9300 Campus Point Drive, Mail Code 7893, La Jolla, CA 92037, USA.
  • Friedman RA; Division of Otolaryngology-Head and Neck Surgery, University of California San Diego School of Medicine, 200 West Arbor Drive, MC 8895, San Diego, CA 92103, USA; Department of Neurosurgery, University of California San Diego School of Medicine, 9300 Campus Point Drive, Mail Code 7893, La Jolla, CA 92037, USA. Electronic address: rafriedman@ucsd.edu.
Otolaryngol Clin North Am ; 56(3): 533-541, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36964092
ABSTRACT
Neurofibromatosis type 2 (NF2) is an autosomal dominant syndrome caused by a mutation in the NF2 suppressor gene and is characterized by the development of multiple benign tumors throughout the central nervous system. Bilateral vestibular schwannomas (VSs) are pathognomonic for NF2 and are associated with progressive hearing loss and eventual deafness in most patients. This review presents current management options for NF-2-associated VSs.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuroma Acústico / Neurofibromatosis 2 / Pérdida Auditiva Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Otolaryngol Clin North Am Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neuroma Acústico / Neurofibromatosis 2 / Pérdida Auditiva Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Otolaryngol Clin North Am Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos